News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|April 5, 2022

Dr. Amy Paller discusses long-term safety and efficacy of ixekizumab in kids

Author(s)Miranda Hester

Dr. Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.

Dr. Paller discusses the findings of the clinical trial discussing the long-term effects of ixekizumab for treating psoriasis in children.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Phase 3 findings support single-dose zoliflodacin for uncomplicated gonorrhea | Image Credit: ©Giovanni Cancemi - stock.adobe.com.

Phase 3 findings support single-dose zoliflodacin for uncomplicated gonorrhea

ByMorgan Ebert, Managing Editor

December 11th 2025

FDA approves gepotidacin as oral treatment for urogenital gonorrhea

FDA approves gepotidacin as oral treatment for urogenital gonorrhea

ByMorgan Ebert, Managing Editor

December 11th 2025

FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome | Image credit: Contemporary Pediatrics

FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome

ByJoshua Fitch, Senior Editor

December 10th 2025

FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia | Image credit: Contemporary Pediatrics

FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia

ByJoshua Fitch, Senior Editor

December 8th 2025

ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B | Image Credit: © jarun011 - © jarun011 - stock.adobe.com.

ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B

ByJoshua Fitch, Senior Editor

December 8th 2025

Latest CME

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA approves gepotidacin as oral treatment for urogenital gonorrhea

FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome

Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV

Can you diagnose this slender teen with a growing abdomen and shrinking height velocity?

Vaccines in childhood linked to lower drug-resistant bacteria risk

© 2025 MJH Life Sciences^®

All rights reserved.